Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
  • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
  • C07D487/04—Ortho-condensed systems
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
  • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
  • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
  • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
  • A61K51/04—Organic compounds
  • A61K51/041—Heterocyclic compounds
  • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
  • A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
  • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
  • C07B59/002—Heterocyclic compounds
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
  • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
  • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
  • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
  • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• General Health & Medical Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Pharmacology & Pharmacy (AREA)
• Medicinal Chemistry (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Epidemiology (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• General Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Neurosurgery (AREA)
• Neurology (AREA)
• Biomedical Technology (AREA)
• Physics & Mathematics (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Optics & Photonics (AREA)
• Psychiatry (AREA)
• Hospice & Palliative Care (AREA)
• Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Nitrogen Condensed Heterocyclic Rings (AREA)
• Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
• Hydrogenated Pyridines (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=53269446

Family Applications (1)

Country Status (21)

Families Citing this family (22)

Family Cites Families (16)

• 2015
  • 2015-05-12 CN CN201580025219.XA patent/CN106459059B/zh active Active
  • 2015-05-12 KR KR1020167034871A patent/KR102530129B1/ko active Active
  • 2015-05-12 WO PCT/EP2015/060447 patent/WO2015173225A1/en not_active Ceased
  • 2015-05-12 CN CN201910795177.8A patent/CN110483522B/zh active Active
  • 2015-05-12 RS RS20210532A patent/RS61810B1/sr unknown
  • 2015-05-12 PL PL15725253T patent/PL3143011T3/pl unknown
  • 2015-05-12 AU AU2015261008A patent/AU2015261008B2/en active Active
  • 2015-05-12 ES ES15725253T patent/ES2867814T3/es active Active
  • 2015-05-12 DK DK15725253.7T patent/DK3143011T3/da active
  • 2015-05-12 HU HUE15725253A patent/HUE053939T2/hu unknown
  • 2015-05-12 KR KR1020237006997A patent/KR102618139B1/ko active Active
  • 2015-05-12 HR HRP20210641TT patent/HRP20210641T1/hr unknown
  • 2015-05-12 SG SG10201805628TA patent/SG10201805628TA/en unknown
  • 2015-05-12 CA CA2948721A patent/CA2948721C/en active Active
  • 2015-05-12 EP EP15725253.7A patent/EP3143011B1/en active Active
  • 2015-05-12 IL IL280791A patent/IL280791B2/en unknown
  • 2015-05-12 EP EP21155891.1A patent/EP3901145A1/en active Pending
  • 2015-05-12 SG SG11201609281UA patent/SG11201609281UA/en unknown
  • 2015-05-12 JP JP2016567651A patent/JP6529986B2/ja active Active
  • 2015-05-12 MX MX2020010847A patent/MX384604B/es unknown
  • 2015-05-12 RU RU2016147742A patent/RU2696492C2/ru active
  • 2015-05-12 SI SI201531590T patent/SI3143011T1/sl unknown
  • 2015-05-12 PT PT157252537T patent/PT3143011T/pt unknown
  • 2015-05-12 LT LTEP15725253.7T patent/LT3143011T/lt unknown
  • 2015-05-12 MX MX2016014615A patent/MX376163B/es active IP Right Grant
• 2016
  • 2016-01-26 US US15/006,997 patent/US10076581B2/en active Active
  • 2016-11-01 IL IL248692A patent/IL248692B/en active IP Right Grant
• 2018
  • 2018-07-31 US US16/050,453 patent/US10675367B2/en active Active
• 2019
  • 2019-05-14 AU AU2019203369A patent/AU2019203369B2/en active Active
  • 2019-05-15 JP JP2019091813A patent/JP6681498B2/ja active Active
  • 2019-12-22 IL IL271631A patent/IL271631B/en active IP Right Grant
• 2020
  • 2020-06-08 US US16/895,352 patent/US11504440B2/en active Active
• 2022
  • 2022-11-18 US US18/056,856 patent/US12214058B2/en active Active

Also Published As

Similar Documents